What is Gene Biotherapeutics, Inc.'s annual revenue?

Gene Biotherapeutics, Inc. (CRXM) reported annual revenue of $0 in its most recent fiscal year.

What is Gene Biotherapeutics, Inc.'s net profit?

Gene Biotherapeutics, Inc. (CRXM) reported net profit of $-1.0M in its most recent fiscal year.

What is CRXM EV/EBITDA?

Gene Biotherapeutics, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.70.

OTC · Financial Statements

Gene Biotherapeutics, Inc. (CRXM) Financial Statements

$0.00 OTC: CRXM Market Cap $6493

Gene Biotherapeutics, Inc. most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2016	2017	2018	2019	2020
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-3.0M	$-2.0M	$-1.0M	$-1.0M	$-1.0M
Net Profit	$-3.0M	$-2.0M	$0	$1.0M	$-1.0M
EPS	$-0.22	$-0.13	$-0.03	$0.06	$-0.02
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2016	2017	2018	2019	2020
Total Assets	$1.0M	$0	$0	$0	$1.0M
Total Liabilities	$4.0M	$5.0M	$6.0M	$5.0M	$5.0M
Cash	$1.0M	$0	$0	$0	$0
Borrowings	$1.0M	$1.0M	$1.0M	$1.0M	$1.0M

Cash Flow (USD)

Metric	2016	2017	2018	2019	2020
Operating Cash Flow	$-2.0M	$-1.0M	$0	$0	$-1.0M
Investing Cash Flow	$0	$0	$1.0M	$0	$0
Financing Cash Flow	$1.0M	$0	$0	$0	$0
Net Cash Flow	$1.0M	$-1.0M	$0	$0	$0
Free Cash Flow	$-2.0M	$-1.0M	$0	$0	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.70
FCF Yield	-17502.51%
Quick Ratio	0.08
Interest Coverage	-21.99
Return 1Y	—
Return 3Y	—
Return 5Y	—

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

CRXM Overview CRXM Dividend Run Stock Screener